News for Blackhawk Growth Corp. (BLR.CN)

Blackhawk Growth Corp. and MindBio Therapeutics Corp have announced the completion of the previously announced statutory plan of arrangement . As part of the Arrangement, Blackhawk... | May 4, 2023

Blackhawk and MindBio Complete Plan Of Arrangement, Shares Spinout

The psychedelics space is up and running. Together with the start of the new year, two companies have shared their latest financial decisions toward advancing their medical business programs.

Blackhawk Growth Corp. (OTCMKTS: BLRZF), an investment holding company focused on acquiring and developing high-growth companies in the health, cannabis and psychedelics sectors in the US and Canada, announced it intends to complete a spin-out transaction of its wholly-owned subsidiaries MindBio Therapeutics Pty. Ltd.

Mindbio Therapeutics, a subsidiary of cannabis and psychedelics holding company Blackhawk Growth Corp.

These corporate claims were filed with the BC Supreme Court registry in Vancouver. Information is derived from notices of civil claim.

Psychedelics policy action took center stage this week.

Mindbio Therapeutics, a company of the Blackhawk Growth Corp. (OTCPK: BLRZF) announced the completion of the world’s largest Phase 1 clinical ...

Management Discussion and Analysis For the financial years ended September 30, 2021 and 2020 This management's discussion and analysis of... | January 31, 2022

DGAP-News: Blackhawk Growth Corp. / Key word: Study/Study results BLACKHAWK GROWTH'S MINDBIO THERAPEUTICS COMPLETES SAFETY MILESTONE IN ITS PHASE 1 CLINICAL TRIALS 2021-11-08 / 12:10 The issuer is... | November 8, 2021

Vancouver, British Columbia - TheNewswire - September 23, 2021 - Blackhawk Growth Corp. (CNSX:BLR.CN) (OTC:BLRZF) (Frankfurt:0JJ) (the 'Company'...